Literature DB >> 9287157

Cloning, overexpression, and biochemical characterization of the catalytic domain of MutY.

R C Manuel1, R S Lloyd.   

Abstract

Proteolysis of MutY with trypsin indicated that this DNA mismatch repair enzyme could exist as two modules and that the N-terminal domain (Met1-Lys225), designated as p26, could serve as the catalytic domain [Manuel et al. (1996) J. Biol. Chem. 271, 16218-16226]. In this study, the p26 domain has been cloned, overproduced, and purified to homogeneity. Synthetic DNA duplexes containing mismatches, generated with regular bases and nucleotide analogs containing altered functional groups, have been used to characterize the substrate specificity and mismatch repair efficiency of p26. In general, p26 recognized and cleaved most of the substrates which were catalyzed by the intact protein. However, p26 displayed enhanced specificity for DNA containing an inosine. guanine mismatch, and the specificity constant (Kcat/Km) was 2-fold higher. The truncated MutY was able to cleave DNA containing an abasic site with equal efficiency. Dissociation constants (Kd) were obtained for p26 on noncleavable DNA substrates containing a tetrahydrofuran (abasic site analog) or a reduced abasic site. p26 bound these substrates with high specificity, and the Kd values were 3-fold higher when compared to the intact MutY. p26 contains both DNA glycosylase and AP lyase activities, and we provide evidence for a reaction mechanism that proceeds through an imino intermediate. Thus, we have shown for the first time that deletion of 125 amino acids at the C-terminus of MutY generates a stable catalytic domain which retains the functional identity of the intact protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9287157     DOI: 10.1021/bi9709708

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  Efficient recognition of substrates and substrate analogs by the adenine glycosylase MutY requires the C-terminal domain.

Authors:  N H Chmiel; M P Golinelli; A W Francis; S S David
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

2.  Intact MutY and its catalytic domain differentially contact with A/8-oxoG-containing DNA.

Authors:  X Li; A L Lu
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

3.  DNA-mediated charge transport for DNA repair.

Authors:  Elizabeth M Boon; Alison L Livingston; Nikolas H Chmiel; Sheila S David; Jacqueline K Barton
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-14       Impact factor: 11.205

Review 4.  Overview of base excision repair biochemistry.

Authors:  Yun-Jeong Kim; David M Wilson
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

5.  Physical and functional interactions between Escherichia coli MutY glycosylase and mismatch repair protein MutS.

Authors:  Haibo Bai; A-Lien Lu
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

6.  Repair of hydantoins, one electron oxidation product of 8-oxoguanine, by DNA glycosylases of Escherichia coli.

Authors:  T K Hazra; J G Muller; R C Manuel; C J Burrows; R S Lloyd; S Mitra
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

7.  Substrate recognition by Escherichia coli MutY using substrate analogs.

Authors:  C L Chepanoske; S L Porello; T Fujiwara; H Sugiyama; S S David
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

8.  Physical and functional interactions between Escherichia coli MutY and endonuclease VIII.

Authors:  A-Lien Lu; Chih-Yung Lee; Lina Li; Xianghong Li
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

9.  Insights into the role of Val45 and Gln182 of Escherichia coli MutY in DNA substrate binding and specificity.

Authors:  Po-Wen Chang; Amrita Madabushi; A-Lien Lu
Journal:  BMC Biochem       Date:  2009-06-12       Impact factor: 4.059

10.  Base excision repair and the role of MUTYH.

Authors:  Carla Kairupan; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2007-12-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.